Linda Williams
Linda brings a rare 360-degree view of the hormone health and compounding industry: supply chain, compounding, practice development, and provider education. She understands the unique operational and commercial challenges facing telemedicine platforms, national chains and franchises, and individual prescriber practices, including patient acquisition and retention, profitability, operational efficiency, and sustainable growth.
Over more than 15 years, Linda has helped scale PE-backed healthcare organizations across 503A/503B compounding pharmacy, cGMP manufacturing, education, and technology-enabled healthcare services. As Chief Growth Officer at Belmar Pharma Solutions, she held combined CRO and CMO responsibility, helped drive 11x revenue growth, and integrated seven acquired brands into a unified national market presence.
As Co-Founder of the Hormonal Health Institute, a CME-accredited provider education platform serving more than 15,000 prescribers worldwide, Linda has direct visibility into how clinicians are educated, how they evaluate therapies and industry partners, what drives adoption, and what practices need to successfully incorporate hormone therapy into patient care. She leads the strategic direction and commercial strategy for HHI.
This combination gives Linda an unusually practical perspective on the full hormone health ecosystem, from the manufacturer and compounding pharmacy through the prescribing clinician and ultimately to the patient.
In addition to her work advising private equity firms and portfolio companies to evaluate investments, Linda also works with healthcare founders, and physician-led organizations evaluating or operating businesses in hormone health, women's health, telemedicine, compounding, longevity, and adjacent healthcare markets. Her work includes growth strategy, go-to-market development, clinician engagement, practice growth strategy, brand integration, and identifying operational and commercial barriers to scale.
Linda is available for private equity advisory, fractional executive leadership, and strategic consulting engagements.
